The results of a new study show the rate of colon cancer death in the United States for people with low socioeconomic status increased between 1980 and 2008 while it decreased during the same period ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor agonists.

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

A study of 6,800 colon cancer patients found those who took Ozempic or Mounjaro were more likely to survive the disease. It may boil down to inflammation.

A new study now shows more younger people are developing and dying from colorectal cancers. The study, published in the Journal of the American Medical Association, found that more white Americans ...

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

New research reveals that certain social determinants of health—such as socioeconomic status, household characteristics, and ...

Deaths from cancer have declined by 33% since 1991, averting 4.1 million deaths. However, more people are being diagnosed with cancer than ever before, and at an earlier age, according to a major new ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

Regular exercise could help cancer patients live longer, new research suggests. The findings come from a study that randomly divided 889 colon cancer patients into two groups – one that adopted a ...

New research reveals that certain social determinants of health-such as socioeconomic status, household characteristics, and racial/ethnic minority status-have significant effects on rural–urban ...

Don’t stall — your butt is on the line. Because of this worrisome trend, the US Preventive Services Task Force (USPSTF) lowered its recommendation for starting colorectal cancer screening from age 50 ...